Category Pharmaceuticals
The coronavirus vaccines are here. Now what?
Maya J. Goldenberg prepares us for the reality that an effective vaccine may stop the pathogen, but it will not establish health.
Health risks of Chloroquine use for COVID-19 in Brazil
Fernando Hellmann argues that the Brazilian Ministry of Health Guidelines for early drug treatment of patients diagnosed with COVID-19 is not based on scientific criteria and puts the health of Brazilians at risk.
Why did I sign the open letter in support of Pharmacare?
Wasem Alsabbagh shows that universal pharmacare is the natural product of the core values of Canada’s health care system and that it is cost-saving.
Request in Support of Universal Pharmacare
Since the 1960s, five national commissions have recommended universal pharmacare for Canada. The most recent of these is the detailed and strategic report of the Advisory Council on the Implementation of National Pharmacare. Now, after more than 50 years of waiting, Canada is close to adding prescription drugs to our “medicare” system. This is extremely […]
Conflicts of Interest: The case of Diclectin
Naila Ramji advocates for the importance of clinical trial transparency.
Impact Ethics 